Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
David R Powell, Deon Doree, Sabrina Jeter-Jones, Zhi-Ming Ding, Brian Zambrowicz, Arthur Sands Lexicon Pharmaceuticals, The Woodlands, TX, USA Purpose: Oral agents are needed that improve glycemic control without increasing hypoglycemic events in patients with type 1 diabetes (T1D). Sotagliflozin...
Guardado en:
Autores principales: | Powell DR, Doree D, Jeter-Jones S, Ding ZM, Zambrowicz B, Sands A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1034519483334cc29f9be744afccfd80 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque
por: Powell DR, et al.
Publicado: (2016) -
Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Robert G Moses
Publicado: (2010) -
Glycemic control and anti-osteopathic effect of propolis in diabetic rats
por: Al-Hariri M, Gamal Eldin T, et al.
Publicado: (2011) -
Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Michael A Via, et al.
Publicado: (2010) -
The role of insulin glulisine to improve glycemic control in children with diabetes mellitus
por: Carter J, et al.
Publicado: (2010)